...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Clinical lymphoma, myeloma & leukemia >Identifying Professional Education Gaps and Barriers in Multiple Myeloma Patient Care: Findings of the Managing Myeloma Continuing Educational Initiative Advisory Committee
【24h】

Identifying Professional Education Gaps and Barriers in Multiple Myeloma Patient Care: Findings of the Managing Myeloma Continuing Educational Initiative Advisory Committee

机译：找出多发性骨髓瘤患者护理中的专业教育空白和障碍：管理性骨髓瘤继续教育倡议咨询委员会的调查结果

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Advances in the past decade and a half have led to unprecedented improved outcomes for patients with multiple myeloma (MM), and this disease appears to be transitioning to one more characteristic of a chronic disease in large part due to rapid translation of clinical insights into practice at the community level. Although evidence-based guidelines and consensus recommendations remain an important resource for managing cancer patients, they do not fill the gap between the principles of disease management today and the translation of tailoring treatment for individual patient needs. Thus, there is a continuing need for concise, focused educational activities and resources that facilitate improved knowledge and understanding of appropriate, individualized therapeutic strategies for assessing and caring for patients with MM. The next several years will truly be a time of shifting paradigms in the treatment of MM in which new agents will be approved, response criteria will be updated, and new approaches to risk assessment and monitoring minimal residual disease will evolve and enter practice. New groundbreaking therapeutic approaches, such as immunotherapy, might result in significant changes in how MM is treated and managed over the entire life cycle of the disease. Even the definition of the disease might be further amended as insights grow regarding who should be treated and who might benefit more from observation. As such, oncology clinicians will have to carefully review and update their management approaches accordingly even as they begin to focus even more on the survivorship needs of their MM patients.
机译：在过去的十五年中，进展已导致多发性骨髓瘤（MM）患者获得空前的改善，该疾病似乎正在转变为一种慢性疾病的另一特征，这在很大程度上是由于将临床见解迅速转化为实践在社区一级。尽管基于证据的指南和共识性建议仍然是管理癌症患者的重要资源，但它们并未填补当今疾病管理原则与针对个别患者需求的量身定制治疗之间的鸿沟。因此，持续需要简明的，有针对性的教育活动和资源，以促进对用于评估和照顾MM患者的适当的，个性化的治疗策略的认识和理解。未来几年将是改变MM治疗范式的时期，新的药物将被批准，反应标准将被更新，风险评估和监测最小残留疾病的新方法将逐步发展并进入实践。新的突破性治疗方法（例如免疫疗法）可能会导致MM在疾病整个生命周期中的治疗和管理方式发生重大变化。随着对谁应该被治疗以及谁将从观察中受益的见解越来越多，甚至可以进一步修改疾病的定义。因此，即使肿瘤科医师开始更加关注其MM患者的生存需求，他们也必须相应地仔细审查和更新其治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号